Article
Relationship between acetylation polymorphism and risk of atopic diseases.
Clinical pharmacology and therapeutics - 1 May 1999
Gawrońska-Szklarz B, Luszawska-Kutrzeba T, Czaja-Bulsa G, Kurzawski G
Abstract excerpt
It has been shown that slow acetylation rate may be a factor that influences the development of allergic diseases. The influence of NAT2 genetic polymorphism on the risk of development of atopic diseases was evaluated among the white Polish population of 85 patients with atopy (62 children and 23 parents) and 181 healthy individuals (127 children and 54 adults). The NAT2 alleles (*4, *5, *6, and *7) were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
